世界のヘルスケアCMO市場。タイプ別(医薬品、医療機器)、地域別(北米、欧州、アジア太平洋、ROW)、COVID-19の影響を受けたサイズと傾向の分析、2027年までの予測Global Healthcare CMO Market: Analysis By Type (Pharmaceutical and Medical Device), By Region (North America, Europe, Asia Pacific, ROW), Size and Trends with Impact of COVID-19 and Forecast up to 2027 世界のヘルスケアCMO市場は、2021年に1,159億米ドルとなり、2027年には2,302億4千万米ドルに成長すると予測されています。ヘルスケアCMO(ヘルスケア受託製造機関)とは、法的な契約に基づいて一定期間、医薬品開... もっと見る
サマリー世界のヘルスケアCMO市場は、2021年に1,159億米ドルとなり、2027年には2,302億4千万米ドルに成長すると予測されています。ヘルスケアCMO(ヘルスケア受託製造機関)とは、法的な契約に基づいて一定期間、医薬品開発・製造などの包括的なサービスを提供する企業です。ヘルスケア業界において、CMO(Contract Manufacturing Organization)は、製薬会社や病院などにサービスを提供します。プレフォーミュレーション、製剤開発、安定性試験、製法開発、前臨床試験および第I相臨床試験用資材、後期臨床試験用資材などのサービスが提供されます。世界のヘルスケアCMO市場は、2022年から2027年の予測期間において、12.12%のCAGRで成長することが決定しています。 市場セグメンテーション分析。 タイプ別。本レポートでは、タイプ別に2つのセグメントを識別しています。医薬品と医療機器である。医薬品CMOセグメントは、さらにサービスに基づいて2つのセグメントに分けられます。医薬品原薬(API)およびその他です。デバイス製造分野は、予測期間中、CAGR13%と最も速い速度で市場が成長すると予想されます。これは、社内製造施設の不足と複雑さにより、デバイス製造のアウトソーシングが増加しているためです。CMOは、サプライチェーンマネジメントのほか、品質管理システム、組み立て、統合、テストの能力を備えており、経験豊富なメーカーは、予測期間中に医療機関と迅速に提携できる体制を整えています。 地域別。本レポートでは、世界のヘルスケアCMO市場を4つの地域に分類しています。北米、欧州、アジア太平洋地域、ROWです。北米は、2021年の世界市場の37%以上の最大シェアを占めています。北米の市場は、同地域が創薬と製造のアウトソーシングに重点を置くようになったことが要因となっています。同地域では、薬剤の発見と開発につながる疾患メカニズムの科学的探求の利用が増加しています。前臨床試験は、医薬品の研究において重要な段階です。この段階では、医薬品が臨床試験に耐えうるかどうかを判断するために、いくつかの試験が実施されます。 アジア太平洋地域は、予測期間中に著しく高い成長率を示すと予測されています。この地域のさまざまな国の政府は、COVID-19の大流行に対抗するために、人工呼吸器などの生命維持装置の生産を加速させるために、地元のCMOと大規模な契約を結んでいます。そのため、人工呼吸器などの医療機器は、患者の生命維持のために、より重要なものとなっています。したがって、当局とCMOの協力は人工呼吸器の増産につながり、予測期間中の市場成長を後押しするものと思われます。 市場ダイナミクス 成長の原動力。市場拡大の主な要因の1つは、ハーブ製品への傾倒が高まっていることです。近年、消費者は自然/ハーブの美容製品を強く好む傾向にあるため、化粧品やパーソナルケア製品にハーブの成分が使用されることが多くなっています。また、消費者のニーズの高まりや持続可能な原材料の確保を背景に、合成化学物質から天然成分への切り替えに力を入れる企業も増えています。このような継続的な需要に対応するため、企業は製造プロセスを第三者機関であるCMOに移行しており、これが化粧品およびパーソナルケア分野におけるCMOの成長を助け、市場の成長を後押ししています。その他の重要な成長要因としては、高齢者人口の急増、医療費の増加、慢性疾患の蔓延、ジェネリック医薬品需要の増加、原薬の需要増などが挙げられます。 課題しかし、急速な技術進歩や特許・著作権・商標・企業秘密への依存など、いくつかの課題が市場の成長を阻害しています。業界のプレーヤーは、ノウハウ、企業秘密、特許、著作権、商標、その他の知的財産権に関する法律、秘密保持契約、その他の契約条項、技術的手段を組み合わせて、企業の提供物や無形資産の多くを保護しています。これらの財産権は、継続的な事業活動にとって重要なものです。当社の一部の製品にかかる独占的権利は特許により保護されていますが、その一部は近い将来失効する可能性があります。特許が失効した場合、独占権の喪失により、企業は第三者との競争を余儀なくされる可能性があり、その結果、売上及び収益性に悪影響を及ぼすと同時に、業界の成長も阻害される可能性があります。 動向。人工知能技術の役割のエスカレートと高度な呼吸器機器の進化により、予測期間中、市場は速いペースで成長すると予測されます。ヘルスケアの人工知能(AI)は、反復作業、治療計画の設計、投薬管理、創薬などを支援することで変貌を遂げました。また、データの収集、保存、正規化により、ヘルスケアデータ管理にも効果的に利用できる。受託製造企業は、AIやその他の技術革新を取り入れることで、より費用対効果が高くなり、生産時間を短縮しています。さらに、医薬品CMOは、より優れたリスク検出を促進し、ひいては医薬品の品質と安全性を向上させるために、常にAI技術の開発に取り組んでいます。 COVID-19の影響分析および今後の方向性。 COVID-19のパンデミックは、世界中で公衆衛生上の大きな懸念となっています。しかし、CMOが提供するバイオ医薬品サービスの増加により、市場にはポジティブな需要ショックが発生しました。CMOは、大量生産に対応するための設備投資や買収を進めています。このパンデミックは、継続的な供給のために、より高い生産量を確保するための設備やバイオプロセシング装置が飛躍的に成長する時代であることを証明しています。 ヘルスケアCMO市場におけるワクチンの開発・製造活動は、主にCOVID-19の大流行に対する業界の対応により、昨年から活発化しています。このような拡大は、今後数年間も続くと予想されます。CMOは、サプライチェーンの課題に対応するため、能力およびリソースへの投資を行っています。CMO業界では、モジュールの建設や拡張、最先端技術への投資、プロセスの集約化戦略が増加しています。さらに、多くのCMOが[メッセンジャーRNA]mRNAや細胞・遺伝子治療などの新しいモダリティで能力を拡大しており、これがポストCOVID期間中の市場の成長を後押しすることになるでしょう。 競合他社の状況 世界のヘルスケアCMO市場は中規模にまとまっています。戦略的提携もまた、競争上の優位性を得るために用いられる一般的な戦略である。例えば、キャタレントは2020年2月、Zumutor Biologics Inc.と、固形腫瘍を治療するZumutorのZM008を製造する契約を締結した。 世界のヘルスケアCMO市場の主なプレイヤーは以下の通りです。 キャタレント・ファーマ・ソリューションズ(Catalent Pharma Solutions, Inc. サムスンバイオロジクス Co.Ltd. オーロビンド ファーマ リミテッド ベーリンガーインゲルハイムGmbH インテージ・ホールディングス株式会社 ピラマル・エンタープライズ・リミテッド ロンザグループAG Koninklijke DSM N.V. (Royal DSM) サーモフィッシャーサイエンティフィック レシプファームAB ファレバグループ シンビオシス ファーマシューティカル サービス ヘルスケアCMO市場の主要プレイヤーは、詳細な競争環境を提供し、必要な承認を得て新規製品を発売することに注力しています。研究開発の必要性は継続的にあり、市場プレイヤーの間では依然として重要な戦略となっています。これらの主要なプレーヤーは、今後数年間で市場の見通しを拡大するために、斬新な戦略を実施しています。2021年4月、サーモフィッシャーサイエンティフィックは、バイオテクノロジー業界への医薬品製造および臨床研究サービスのグローバルプロバイダーであるPPD社の買収を発表した。これにより、同社の製造能力と顧客基盤の拡大により、市場での地位が向上する。2021年5月、Samsung BiologicsとModerna Inc.は、ModernaのCOVID-19ワクチンの充填・仕上げサービスを提供するための提携を発表した。 目次1. Executive Summary2. Introduction 2.1 Healthcare Contract Manufacturing Organization (CMO): An Overview 2.1.1 Benefits Of Healthcare CMOs 2.2 Healthcare CMO Segmentation: An Overview 2.2.1 Healthcare CMO Segmentation 3. Global Market Analysis 3.1 Global Healthcare Contract Manufacturing Organization (CMO) Market: An Analysis 3.1.1 Global Healthcare CMO Market: An Overview 3.1.2 Global Healthcare Contract Manufacturing Organization (CMO) Market by Value 3.1.3 Global Healthcare Contract Manufacturing Organization (CMO) Market by Type (Pharmaceutical and Medical Device) 3.1.4 Global Healthcare Contract Manufacturing Organization (CMO) Market by Region (North America, Europe, Asia Pacific, and rest of the World (ROW) 3.2 Global Healthcare CMO Market: Type Analysis 3.2.1 Global Healthcare CMO Market by Type: An Overview 3.2.2 Global Pharmaceutical CMO Market by Value 3.2.3 Global Pharmaceutical CMO Market by Service (Active Pharmaceutical Ingredients (API) and Others) 3.2.3 Global Pharmaceutical CMO Market by Service: An Overview 3.2.4 Global Active Pharmaceutical Ingredients (API) CMO Market by Value 3.2.5 Global Other Pharmaceuticals CMO Market by Value 3.2.6 Global Medical Devices CMO Market by Value 4. Regional Market Analysis 4.1 North America Healthcare CMO Market: An Analysis 4.1.1 North America Healthcare CMO Market: An Overview 4.1.2 North America Healthcare CMO Market by Value 4.1.3 North America Healthcare CMO Market by Region (The US, Canada and Mexico) 4.1.4 The US Healthcare CMO Market by Value 4.1.5 The US Healthcare CMO Market by Type (Pharmaceutical and Medical Device) 4.1.6 The US Pharmaceutical Healthcare CMO Market by Value 4.1.7 The US Medical Devices Healthcare CMO Market by Value 4.1.8 Canada Healthcare CMO Market by Value 4.1.9 Mexico Healthcare CMO Market by Value 4.2 Europe Healthcare CMO Market: An Analysis 4.2.1 Europe Healthcare CMO Market: An Overview 4.2.2 Europe Healthcare CMO Market by Value 4.2.3 Europe Healthcare CMO Market by Region (Germany, The UK, France, Italy, Spain, and Rest of the Europe) 4.2.4 Germany Healthcare CMO Market by Value 4.2.5 The UK Healthcare CMO Market by Value 4.2.6 France Healthcare CMO Market by Value 4.2.7 Italy Healthcare CMO Market by Value 4.2.8 Spain Healthcare CMO Market by Value 4.2.9 Rest of Europe Healthcare CMO Market by Value 4.3 Asia Pacific Healthcare CMO Market: An Analysis 4.3.1 Asia Pacific Healthcare CMO Market: An Overview 4.3.2 Asia Pacific Healthcare CMO Market by Value 4.3.3 Asia Pacific Healthcare CMO Market by Region (China, Japan, India, South Korea, and Rest of the Asia Pacific) 4.3.4 China Healthcare CMO Market by Value 4.3.5 Japan Healthcare CMO Market by Value 4.3.6 India Healthcare CMO Market by Value 4.3.7 South Korea Healthcare CMO Market by Value 4.3.8 Rest of Asia Pacific Healthcare CMO Market by Value 4.4 Rest of World Healthcare CMO Market: An Analysis 4.4.1 Rest of World Healthcare CMO Market: An Overview 4.4.2 Rest of World Healthcare CMO Market by Value 5. Impact of Covid-19 5.1 Surge in Contracts to CDMOs 5.2 Supply Chain Issues Amidst Surge in Demand for CDMOs 5.3 Preparedness Measures in the Event of Supply Chain Disruption 5.4 Post-COVID Scenario 6. Market Dynamics 6.1 Growth Drivers 6.1.1 Surging Geriatric Population 6.1.2 Rising Healthcare Expenditure 6.1.3 Increasing Spread of Chronic Diseases 6.1.4 Escalating Demand for Generic Drugs 6.1.5 Growing Inclination Towards Herbal Products 6.1.6 Increasing Demand for Active Pharmaceutical Ingredient (API) 6.2 Challenges 6.2.1 Rapid Technological Advancements 6.2.2 Dependent on Patents, Copyrights, Trademarks and Trade Secrets 6.3 Market Trends 6.3.1 Escalating Role of Artificial Intelligence Technology 6.3.2 Evolution of Advanced Respiratory Equipment 7. Competitive Landscape 7.1 Global Healthcare CMO Market Players Financial Comparison 7.2 Global Healthcare CMO Market Players by Research & Development (R&D) Expenses 8. Company Profiles 8.1 Catalent Pharma Solutions Inc. 8.1.1 Business Overview 8.1.2 Operating Segments 8.1.3 Business Strategy 8.2 Samsung Biologics Co. Ltd. 8.2.1 Business Overview 8.2.2 Operating Segments 8.2.3 Business Strategy 8.3 Aurobindo Pharma Limited 8.3.1 Business Overview 8.3.2 Operating Segments 8.3.3 Business Strategy 8.4 Boehringher Ingelheim 8.4.1 Business Overview 8.4.2 Operating Segments 8.4.3 Business Strategy 8.5 Integer Holdings Corporation 8.5.1 Business Overview 8.5.2 Operating Segments 8.5.3 Business Strategy 8.6 Piramal Enterprises Limited 8.6.1 Business Overview 8.6.2 Operating Segments 8.6.3 Business Strategy 8.7 Lonza Group AG 8.7.1 Business Overview 8.7.2 Operating Segments 8.7.3 Business Strategy 8.8 Koninklijke DSM N.V. (Royal DSM) 8.8.1 Business Overview 8.8.2 Operating Segments 8.8.3 Business Strategy 8.9 Thermo Fisher Scientific Inc. 8.9.1 Business Overview 8.9.2 Operating Segments 8.9.3 Business Strategy 8.10 Recipharm AB 8.10.1 Business Overview 8.10.2 Business Strategy 8.11 Fareva Group 8.11.1 Business Overview 8.11.2 Business Strategy 8.12 Symbiosis Pharmaceutical Services 8.12.1 Business Overview 8.12.2 Business Strategy List of Figures Figure 1: Benefits Of Healthcare CMOs Figure 2: Healthcare CMO Segmentation Figure 3: Global Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 4: Global Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 5: Global Healthcare CMO Market by Type; 2021 (Percentage, %) Figure 6: Global Healthcare CMO Market by Region; 2021 (Percentage, %) Figure 7: Global Pharmaceutical CMO Market by Value; 2017-2021 (US$ Billion) Figure 8: Global Pharmaceutical CMO Market by Value; 2022-2027 (US$ Billion) Figure 9: Global Pharmaceutical CMO Market by Service; 2021 (Percentage, %) Figure 10: Global Active Pharmaceutical Ingredients (API) CMO Market by Value; 2017-2021 (US$ Billion) Figure 11: Global Active Pharmaceutical Ingredients (API) CMO Market by Value; 2022-2027 (US$ Billion) Figure 12: Global Other Pharmaceuticals CMO Market by Value; 2017-2021 (US$ Billion) Figure 13: Global Other Pharmaceuticals CMO Market by Value; 2022-2027 (US$ Billion) Figure 14: Global Medical Devices CMO Market by Value; 2017-2021 (US$ Billion) Figure 15: Global Medical Devices CMO Market by Value; 2022-2027 (US$ Billion) Figure 16: North America Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 17: North America Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 18: North America Healthcare CMO Market by Region; 2021 (Percentage, %) Figure 19: The US Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 20: The US Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 21: The US Healthcare CMO Market by Type; 2021 (Percentage, %) Figure 22: The US Pharmaceutical Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 23: The US Pharmaceutical Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 24: The US Medical Devices Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 25: The US Medical Devices Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 26: Canada Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 27: Canada Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 28: Mexico Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 29: Mexico Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 30: Europe Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 31: Europe Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 32: Europe Healthcare CMO Market by Region; 2021 (Percentage, %) Figure 33: Germany Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 34: Germany Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 35: The UK Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 36: The UK Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 37: France Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 38: France Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 39: Italy Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 40: Italy Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 41: Spain Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 42: Spain Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 43: Rest of Europe Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 44: Rest of Europe Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 45: Asia Pacific Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 46: Asia Pacific Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 47: Asia Pacific Healthcare CMO Market by Region; 2021 (Percentage, %) Figure 48: China Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 49: China Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 50: Japan Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 51: Japan Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 52: India Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 53: India Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 54: South Korea Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 55: South Korea Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 56: Rest of Asia Pacific Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 57: Rest of Asia Pacific Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 58: Rest of World Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 59: Rest of World Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 60: Global Population Proportion Above 65 Years of Age; 2019 & 2030 (Million) Figure 61: Global Healthcare Expenditure; 2017 & 2022 (US$ Trillion) Figure 62: Global Chronic Disease Growth; 2016-2025 (Percentage, %) Figure 63: Global Generic Drugs Market Value, 2020-2025 (US$ Billion) Figure 64: Global Natural And Organic Cosmetics And Personal Care Market Value, 2021-2027 (US$ Billion) Figure 65: Global Healthcare Artificial Intelligence Market Value; 2020-2025 (US$ Billion) Figure 66: The Global Healthcare CMO Market Players by Research & Development (R&D) Expenses; 2020 & 2021 (US$ Million) Figure 67: Catalent, Inc. Net Revenue by Segments; 2021 (Percentage, %) Figure 68: Samsung Biologics Co. Ltd. Revenue by Product Type; 2021 (Percentage, %) Figure 69: Aurobindo Pharma Limited Revenue by Business Segments; 2021 (Percentage, %) Figure 70: Boehringher Ingelheim Net Sales by Segments; 2021 (Percentage, %) Figure 71: Integer Holdings Corporation Net Sales by Segments; 2021 (Percentage, %) Figure 72: Piramal Enterprises Limited Net Sales by Business; 2021 (Percentage, %) Figure 73: Lonza Group AG Sales by Segments; 2021 (Percentage, %) Figure 74: Koninklijke DSM N.V. Net Sales by Business Segments; 2021 (Percentage, %) Figure 75: Thermo Fisher Scientific Inc. Revenues by Segments; 2021 (Percentage, %) Table 1: Contracts Placed with Pharmaceutical CDMOs; 2020 Table 2: Global Healthcare CMO Market Players Financial Comparison; 2021
SummaryThe global healthcare CMO market was valued at US$115.90 billion in 2021, and is predicted to grow to US$230.24 billion in 2027. Healthcare CMOs, or healthcare contract manufacturing organizations, are companies that provide comprehensive services such as drug development and manufacturing for a set period of time under a legal contract. Table of Contents1. Executive Summary2. Introduction 2.1 Healthcare Contract Manufacturing Organization (CMO): An Overview 2.1.1 Benefits Of Healthcare CMOs 2.2 Healthcare CMO Segmentation: An Overview 2.2.1 Healthcare CMO Segmentation 3. Global Market Analysis 3.1 Global Healthcare Contract Manufacturing Organization (CMO) Market: An Analysis 3.1.1 Global Healthcare CMO Market: An Overview 3.1.2 Global Healthcare Contract Manufacturing Organization (CMO) Market by Value 3.1.3 Global Healthcare Contract Manufacturing Organization (CMO) Market by Type (Pharmaceutical and Medical Device) 3.1.4 Global Healthcare Contract Manufacturing Organization (CMO) Market by Region (North America, Europe, Asia Pacific, and rest of the World (ROW) 3.2 Global Healthcare CMO Market: Type Analysis 3.2.1 Global Healthcare CMO Market by Type: An Overview 3.2.2 Global Pharmaceutical CMO Market by Value 3.2.3 Global Pharmaceutical CMO Market by Service (Active Pharmaceutical Ingredients (API) and Others) 3.2.3 Global Pharmaceutical CMO Market by Service: An Overview 3.2.4 Global Active Pharmaceutical Ingredients (API) CMO Market by Value 3.2.5 Global Other Pharmaceuticals CMO Market by Value 3.2.6 Global Medical Devices CMO Market by Value 4. Regional Market Analysis 4.1 North America Healthcare CMO Market: An Analysis 4.1.1 North America Healthcare CMO Market: An Overview 4.1.2 North America Healthcare CMO Market by Value 4.1.3 North America Healthcare CMO Market by Region (The US, Canada and Mexico) 4.1.4 The US Healthcare CMO Market by Value 4.1.5 The US Healthcare CMO Market by Type (Pharmaceutical and Medical Device) 4.1.6 The US Pharmaceutical Healthcare CMO Market by Value 4.1.7 The US Medical Devices Healthcare CMO Market by Value 4.1.8 Canada Healthcare CMO Market by Value 4.1.9 Mexico Healthcare CMO Market by Value 4.2 Europe Healthcare CMO Market: An Analysis 4.2.1 Europe Healthcare CMO Market: An Overview 4.2.2 Europe Healthcare CMO Market by Value 4.2.3 Europe Healthcare CMO Market by Region (Germany, The UK, France, Italy, Spain, and Rest of the Europe) 4.2.4 Germany Healthcare CMO Market by Value 4.2.5 The UK Healthcare CMO Market by Value 4.2.6 France Healthcare CMO Market by Value 4.2.7 Italy Healthcare CMO Market by Value 4.2.8 Spain Healthcare CMO Market by Value 4.2.9 Rest of Europe Healthcare CMO Market by Value 4.3 Asia Pacific Healthcare CMO Market: An Analysis 4.3.1 Asia Pacific Healthcare CMO Market: An Overview 4.3.2 Asia Pacific Healthcare CMO Market by Value 4.3.3 Asia Pacific Healthcare CMO Market by Region (China, Japan, India, South Korea, and Rest of the Asia Pacific) 4.3.4 China Healthcare CMO Market by Value 4.3.5 Japan Healthcare CMO Market by Value 4.3.6 India Healthcare CMO Market by Value 4.3.7 South Korea Healthcare CMO Market by Value 4.3.8 Rest of Asia Pacific Healthcare CMO Market by Value 4.4 Rest of World Healthcare CMO Market: An Analysis 4.4.1 Rest of World Healthcare CMO Market: An Overview 4.4.2 Rest of World Healthcare CMO Market by Value 5. Impact of Covid-19 5.1 Surge in Contracts to CDMOs 5.2 Supply Chain Issues Amidst Surge in Demand for CDMOs 5.3 Preparedness Measures in the Event of Supply Chain Disruption 5.4 Post-COVID Scenario 6. Market Dynamics 6.1 Growth Drivers 6.1.1 Surging Geriatric Population 6.1.2 Rising Healthcare Expenditure 6.1.3 Increasing Spread of Chronic Diseases 6.1.4 Escalating Demand for Generic Drugs 6.1.5 Growing Inclination Towards Herbal Products 6.1.6 Increasing Demand for Active Pharmaceutical Ingredient (API) 6.2 Challenges 6.2.1 Rapid Technological Advancements 6.2.2 Dependent on Patents, Copyrights, Trademarks and Trade Secrets 6.3 Market Trends 6.3.1 Escalating Role of Artificial Intelligence Technology 6.3.2 Evolution of Advanced Respiratory Equipment 7. Competitive Landscape 7.1 Global Healthcare CMO Market Players Financial Comparison 7.2 Global Healthcare CMO Market Players by Research & Development (R&D) Expenses 8. Company Profiles 8.1 Catalent Pharma Solutions Inc. 8.1.1 Business Overview 8.1.2 Operating Segments 8.1.3 Business Strategy 8.2 Samsung Biologics Co. Ltd. 8.2.1 Business Overview 8.2.2 Operating Segments 8.2.3 Business Strategy 8.3 Aurobindo Pharma Limited 8.3.1 Business Overview 8.3.2 Operating Segments 8.3.3 Business Strategy 8.4 Boehringher Ingelheim 8.4.1 Business Overview 8.4.2 Operating Segments 8.4.3 Business Strategy 8.5 Integer Holdings Corporation 8.5.1 Business Overview 8.5.2 Operating Segments 8.5.3 Business Strategy 8.6 Piramal Enterprises Limited 8.6.1 Business Overview 8.6.2 Operating Segments 8.6.3 Business Strategy 8.7 Lonza Group AG 8.7.1 Business Overview 8.7.2 Operating Segments 8.7.3 Business Strategy 8.8 Koninklijke DSM N.V. (Royal DSM) 8.8.1 Business Overview 8.8.2 Operating Segments 8.8.3 Business Strategy 8.9 Thermo Fisher Scientific Inc. 8.9.1 Business Overview 8.9.2 Operating Segments 8.9.3 Business Strategy 8.10 Recipharm AB 8.10.1 Business Overview 8.10.2 Business Strategy 8.11 Fareva Group 8.11.1 Business Overview 8.11.2 Business Strategy 8.12 Symbiosis Pharmaceutical Services 8.12.1 Business Overview 8.12.2 Business Strategy List of Figures Figure 1: Benefits Of Healthcare CMOs Figure 2: Healthcare CMO Segmentation Figure 3: Global Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 4: Global Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 5: Global Healthcare CMO Market by Type; 2021 (Percentage, %) Figure 6: Global Healthcare CMO Market by Region; 2021 (Percentage, %) Figure 7: Global Pharmaceutical CMO Market by Value; 2017-2021 (US$ Billion) Figure 8: Global Pharmaceutical CMO Market by Value; 2022-2027 (US$ Billion) Figure 9: Global Pharmaceutical CMO Market by Service; 2021 (Percentage, %) Figure 10: Global Active Pharmaceutical Ingredients (API) CMO Market by Value; 2017-2021 (US$ Billion) Figure 11: Global Active Pharmaceutical Ingredients (API) CMO Market by Value; 2022-2027 (US$ Billion) Figure 12: Global Other Pharmaceuticals CMO Market by Value; 2017-2021 (US$ Billion) Figure 13: Global Other Pharmaceuticals CMO Market by Value; 2022-2027 (US$ Billion) Figure 14: Global Medical Devices CMO Market by Value; 2017-2021 (US$ Billion) Figure 15: Global Medical Devices CMO Market by Value; 2022-2027 (US$ Billion) Figure 16: North America Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 17: North America Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 18: North America Healthcare CMO Market by Region; 2021 (Percentage, %) Figure 19: The US Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 20: The US Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 21: The US Healthcare CMO Market by Type; 2021 (Percentage, %) Figure 22: The US Pharmaceutical Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 23: The US Pharmaceutical Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 24: The US Medical Devices Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 25: The US Medical Devices Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 26: Canada Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 27: Canada Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 28: Mexico Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 29: Mexico Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 30: Europe Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 31: Europe Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 32: Europe Healthcare CMO Market by Region; 2021 (Percentage, %) Figure 33: Germany Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 34: Germany Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 35: The UK Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 36: The UK Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 37: France Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 38: France Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 39: Italy Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 40: Italy Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 41: Spain Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 42: Spain Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 43: Rest of Europe Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 44: Rest of Europe Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 45: Asia Pacific Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 46: Asia Pacific Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 47: Asia Pacific Healthcare CMO Market by Region; 2021 (Percentage, %) Figure 48: China Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 49: China Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 50: Japan Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 51: Japan Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 52: India Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 53: India Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 54: South Korea Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 55: South Korea Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 56: Rest of Asia Pacific Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 57: Rest of Asia Pacific Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 58: Rest of World Healthcare CMO Market by Value; 2017-2021 (US$ Billion) Figure 59: Rest of World Healthcare CMO Market by Value; 2022-2027 (US$ Billion) Figure 60: Global Population Proportion Above 65 Years of Age; 2019 & 2030 (Million) Figure 61: Global Healthcare Expenditure; 2017 & 2022 (US$ Trillion) Figure 62: Global Chronic Disease Growth; 2016-2025 (Percentage, %) Figure 63: Global Generic Drugs Market Value, 2020-2025 (US$ Billion) Figure 64: Global Natural And Organic Cosmetics And Personal Care Market Value, 2021-2027 (US$ Billion) Figure 65: Global Healthcare Artificial Intelligence Market Value; 2020-2025 (US$ Billion) Figure 66: The Global Healthcare CMO Market Players by Research & Development (R&D) Expenses; 2020 & 2021 (US$ Million) Figure 67: Catalent, Inc. Net Revenue by Segments; 2021 (Percentage, %) Figure 68: Samsung Biologics Co. Ltd. Revenue by Product Type; 2021 (Percentage, %) Figure 69: Aurobindo Pharma Limited Revenue by Business Segments; 2021 (Percentage, %) Figure 70: Boehringher Ingelheim Net Sales by Segments; 2021 (Percentage, %) Figure 71: Integer Holdings Corporation Net Sales by Segments; 2021 (Percentage, %) Figure 72: Piramal Enterprises Limited Net Sales by Business; 2021 (Percentage, %) Figure 73: Lonza Group AG Sales by Segments; 2021 (Percentage, %) Figure 74: Koninklijke DSM N.V. Net Sales by Business Segments; 2021 (Percentage, %) Figure 75: Thermo Fisher Scientific Inc. Revenues by Segments; 2021 (Percentage, %) Table 1: Contracts Placed with Pharmaceutical CDMOs; 2020 Table 2: Global Healthcare CMO Market Players Financial Comparison; 2021
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(プライマリケア)の最新刊レポート
Daedal Research社のプライマリケア分野での最新刊レポート
本レポートと同じKEY WORD(healthcare)の最新刊レポート
よくあるご質問Daedal Research社はどのような調査会社ですか?デダルリサーチ (Daedal Research) はインドとアジアを始めとして世界の医療や医薬、ICT、エネルギー、通信、化学、交通、消費財などの様々な市場を調査対象とした市場調査報告書を出版してい... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |